Departments, Centers, & Programs:
Division of Pulmonary and Critical Care Medicine
55 Fruit Street
Boston, MA 02114
- MD, Harvard Medical School
- Residency, Massachusetts General Hospital
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Internal Medicine, American Board of Internal Medicine
- Pulmonary Disease, American Board of Internal Medicine
- Critical Care Medicine, American Board of Internal Medicine
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Reddy’s research interests include tobacco, HIV, and tuberculosis, both individually and in combination. He applies methods of simulation modeling, epidemiology, and cost-effectiveness analysis to study clinical and economic outcomes in the US and in other countries. The goal of his research is to provide evidence- and model-based approaches to clinical decision-making and public health policy. Dr. Reddy is a faculty investigator in the Medical Practice Evaluation Center (www.massgeneral.org/mpec) and the Tobacco Research and Treatment Center (www.massgeneral.org/trtc), both at MGH.
Dr. Reddy’s work has been reported by NBC News, Reuters, and WBUR/National Public Radio. He has been invited to present his work as a consultant to the World Health Organization. His research is supported by a career development award (K01) from the National Institutes of Health.
Lee DJ, Kumarasamy N, Resch SC, Sivaramakrishnan GN, Mayer KH, Tripathy S, Paltiel AD, Freedberg KA, Reddy KP. Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: cost-effectiveness analysis for India’s public sector. PLoS One 2019;14:e0218890.
Reddy KP, Gupta-Wright A, Fielding KL, Costantini S, Zheng A, Corbett EL, Yu L, van Oosterhout JJ, Resch SC, Wilson DP, Horsburgh CR, Wood R, Alufandika-Moyo M, Peters JA, Freedberg KA, Lawn SD, Walensky RP. Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study. Lancet Glob Health 2019;7:e200.
Murray EJ, Robins JM, Seage GR, Lodi S, Hyle EP, Reddy KP, Freedberg KA, Hernán MA. Using observational data to calibrate simulation models. Med Decis Making 2018;38(2):212.
Reddy KP, Kong CY, Hyle EP, Baggett TP, Huang M, Parker RA, Paltiel AD, Losina E, Weinstein MC, Freedberg KA, Walensky RP. Lung cancer mortality associated with smoking and smoking cessation among people living with HIV in the United States. JAMA Intern Med 2017;177:1613.
Reddy KP, Parker RA, Losina E, Baggett TP, Paltiel AD, Rigotti NA, Weinstein MC, Freedberg KA, Walensky RP. Impact of cigarette smoking and smoking cessation on life expectancy among people with HIV: a US-based modeling study. J Infect Dis 2016;214:1672.
Reddy KP, Brady MF, Gilman RH, Coronel J, Navincopa M, Ticona E, Chavez G, Sánchez E, Rojas C, Solari L, Valencia J, Pinedo Y, Benites C, Friedland JS, Moore DA. Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons. Clin Infect Dis 2010;50:988.